Citadel Advisors
HIMS icon

Citadel Advisors’s Hims & Hers Health HIMS Stock Holding History

Citadel Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.8M Sell
4,179,700
-2,484,700
-37% -$58.7M 0.01% 914
2025
Q4 		$216M Buy
6,664,400
+426,400
+7% +$18.3M 0.03% 449
2025
Q3 		$354M Buy
6,238,000
+1,271,700
+26% +$65.2M 0.05% 279
2025
Q2 		$248M Buy
4,966,300
+2,267,900
+84% +$103M 0.04% 337
2025
Q1 		$79.7M Sell
2,698,400
-86,800
-3% -$3.22M 0.02% 833
2024
Q4 		$67.3M Buy
2,785,200
+1,782,000
+178% +$44.1M 0.01% 1022
2024
Q3 		$18.5M Sell
1,003,200
-210,300
-17% -$3.77M ﹤0.01% 2131
2024
Q2 		$24.5M Buy
1,213,500
+971,500
+401% +$16.2M 0.01% 1793
2024
Q1 		$3.74M Sell
242,000
-160,500
-40% -$1.81M ﹤0.01% 4415
2023
Q4 		$3.58M Sell
402,500
-118,300
-23% -$875K ﹤0.01% 4340
2023
Q3 		$3.28M Buy
520,800
+155,300
+42% +$1.16M ﹤0.01% 4331
2023
Q2 		$3.44M Buy
365,500
+11,700
+3% +$116K ﹤0.01% 4235
2023
Q1 		$3.51M Buy
353,800
+202,900
+134% +$1.78M ﹤0.01% 4387
2022
Q4 		$967K Buy
150,900
+56,100
+59% +$319K ﹤0.01% 6886
2022
Q3 		$529K Buy
94,800
+37,700
+66% +$227K ﹤0.01% 8337
2022
Q2 		$259K Sell
57,100
-47,100
-45% -$201K ﹤0.01% 10144
2022
Q1 		$555K Sell
104,200
-12,000
-10% -$59.4K ﹤0.01% 9133
2021
Q4 		$761K Sell
116,200
-20,200
-15% -$146K ﹤0.01% 8615
2021
Q3 		$1.03M Buy
136,400
+34,600
+34% +$293K ﹤0.01% 8086
2021
Q2 		$1.11M Buy
101,800
+34,000
+50% +$404K ﹤0.01% 8095
2021
Q1 		$897K Buy
+67,800
New +$1.14M ﹤0.01% 8385

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's HIMS Position: Q1 2026 in Review

Citadel Advisors reduced its Hims & Hers Health (HIMS) stake by 65% in Q1 2026, selling an estimated $29.9M and leaving 694,774 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2733.

Citadel Advisors first reported a position in HIMS in Q1 2021 and has held it in 20 quarters since. The position peaked at $63.6M in Q4 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Citadel Advisors held 694,774 shares of Hims & Hers Health worth $14.4M as of Q1 2026.
  • Citadel Advisors sold 1,265,136 Hims & Hers Health shares in Q1 2026, an estimated $29.9M.
  • Hims & Hers Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2733 holding.
  • Citadel Advisors first reported a position in Hims & Hers Health in Q1 2021 and has held it in 20 quarters since.
  • Citadel Advisors's Hims & Hers Health position peaked at $63.6M in Q4 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.